Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Primecap Management Co reported a 9.15% stake in Rhythm Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 13, 2025
Primecap Management Co reported a 9.15% stake in Rhythm Pharmaceuticals, Inc., 5,787,322 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G/A).
- Stake
- 9.15%
- Shares
- 5,787,322
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 9.15% | 5,787,322 |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Primecap Management Co
- Rhythm Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Primecap Management Co · Feb 12, 2026
- Schedule 13G/A · Primecap Management Co · Nov 14, 2025
- Schedule 13G/A · Primecap Management Co · Aug 14, 2025
- Schedule 13G/A · Primecap Management Co · Feb 13, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026